+ Reply to Thread
Page 1 of 2 1 2 LastLast
Results 1 to 10 of 18

Thread: ARIA - Ariad Pharmaceuticals, Inc. - Huge insider buy & PHASE 3

  1. 08-11-2009 02:53 PM #1
    sofakingcool
    sofakingcool is offline
    Member sofakingcool is just really nice sofakingcool is just really nice sofakingcool is just really nice
    Join Date
    Jul 2009
    Location
    Canton
    Posts
    75
    Rep Power
    93

    Default ARIA - Ariad Pharmaceuticals, Inc. - Huge insider buy & PHASE 3

    ARIA: Insider Transactions for ARIAD Pharmaceuticals, Inc. - Yahoo! Finance

    INSIDER TRANSACTIONS REPORTED - LAST TWO YEARS
    Date Insider Shares Type Transaction Value*
    4-Aug-09 DODION PIERRE F
    Officer 5,714 Indirect Purchase at $1.75 per share. $9,999
    4-Aug-09 BERGER HARVEY J M D
    Officer 1,714,286 Indirect Purchase at $1.75 per share. $3,000,000



    ARIAD Pharmaceuticals, Inc. (ARIA) - Ridaforolimus for Metastatic Sarcoma (Phase III - Interim Analysis)
    First interim efficacy analysis of the Phase III SUCCEED trial of Ridaforolimus as a maintenance therapy for adv

    ARIAD Pharmaceuticals, Inc. ( ARIA ) - UPCOMING EVENT(,8,2009)

    Reply With Quote Reply With Quote  
  2. 08-16-2009 04:10 PM #2
    pcstock
    pcstock is offline
    Senior Member pcstock is just really nice pcstock is just really nice pcstock is just really nice pcstock is just really nice
    Join Date
    Jul 2009
    Location
    Daly City
    Posts
    181
    Rep Power
    106

    Default

    Is there an estimate date for the Phase 3 analysis?
    Reply With Quote Reply With Quote  
  3. 08-16-2009 09:40 PM #3
    jestudley
    jestudley is offline
    Junior Member jestudley is on a distinguished road
    Join Date
    Aug 2009
    Posts
    7
    Rep Power
    74

    Default

    There is always going to be insider buying,if they know something and buy alot of shares,take there advice and buy some too
    good luck
    Reply With Quote Reply With Quote  
  4. 08-17-2009 10:14 AM #4
    flagsaxman
    flagsaxman is offline
    Junior Member flagsaxman is on a distinguished road
    Join Date
    Jul 2009
    Posts
    15
    Rep Power
    77

    Default ARIA upgrade

    ARIA up grade from Oppenheimer.

    Oppenheimer initiates Ariad Pharmaceuticals (ARIA 1.95) with an Outperform and sets a $4 tgt, as they see a good probability of positive Ph. 3 results from ridaforolimus, partnered with MRK, leading to U.S. approval in 4Q10/1Q11, based on strong Ph. 2 sarcoma data. Firm expects a significant PFS benefit for the drug vs. placebo for response maintenance in SUCCEED, either at a 1Q10 interim analysis or in final data in mid-'10

    Source: Briefing.com
    Reply With Quote Reply With Quote  
  5. 09-06-2009 08:40 PM #5
    orestrus
    orestrus is offline
    Junior Member orestrus is on a distinguished road
    Join Date
    Jul 2009
    Posts
    2
    Rep Power
    0

    Default Anyone expects ARIA to follow HGSI

    upon positive results? What is your pps expectation? Thanks
    Reply With Quote Reply With Quote  
  6. 09-07-2009 01:17 AM #6
    TheStockDude
    TheStockDude is offline
    Moderator TheStockDude is a name known to all TheStockDude is a name known to all TheStockDude is a name known to all TheStockDude is a name known to all TheStockDude is a name known to all TheStockDude's Avatar
    Join Date
    Jul 2009
    Location
    New Jersey
    Posts
    111
    Rep Power
    104

    Default

    Quote Originally Posted by orestrus View Post
    upon positive results? What is your pps expectation? Thanks
    Here is the chart:



    I just got into ARIA a couple days ago on the dips. The sotck has been in a nice downtrend since 2005.
    "Wide diversification is only required when investors do not understand what they are doing." - Warren Buffett
    Reply With Quote Reply With Quote  
  7. 09-08-2009 01:12 PM #7
    LRP
    LRP is offline
    Junior Member LRP is on a distinguished road
    Join Date
    Sep 2009
    Posts
    16
    Rep Power
    72

    Default

    Don't forget that these are just the first interim results.

    How much it moves the stock will be based upon either the positive spin or if the data warrants the study being halted (statistical futility, safety, etc.).
    Reply With Quote Reply With Quote  
  8. 09-08-2009 04:54 PM #8
    greedydoc
    greedydoc is offline
    Junior Member greedydoc is on a distinguished road
    Join Date
    Sep 2009
    Location
    syracuse
    Posts
    2
    Rep Power
    0

    Default

    Jumped in today. Something should happen especially with the insider buying.
    Reply With Quote Reply With Quote  
  9. 09-08-2009 06:30 PM #9
    fleipeg
    fleipeg is offline
    Junior Member fleipeg is on a distinguished road
    Join Date
    Sep 2009
    Posts
    2
    Rep Power
    0

    Smile Aria

    Agree .... I anticipate for this stock to get a good bounce once they announce results later this month.
    Reply With Quote Reply With Quote  
  10. 09-08-2009 06:52 PM #10
    flagsaxman
    flagsaxman is offline
    Junior Member flagsaxman is on a distinguished road
    Join Date
    Jul 2009
    Posts
    15
    Rep Power
    77

    Default Aria

    In at $1.80 so obviously I am very happy. GLTA
    Reply With Quote Reply With Quote  
+ Reply to Thread
Page 1 of 2 1 2 LastLast
« S: Sprint | Which of these stocks are still good? »

Similar Threads

  1. ARIA (Ariad pharma)
    By crosuel in forum Hot Stocks
    Replies: 0
    Last Post: 03-10-2010, 10:37 AM
  2. RPRX, Huge gamble - insider trade?
    By apex944 in forum Hot Stocks
    Replies: 0
    Last Post: 10-23-2009, 11:47 AM
  3. Companies with Phase 2/Phase 3 results to report
    By stockgirl88 in forum Hot Stocks
    Replies: 13
    Last Post: 10-02-2009, 11:08 AM
  4. ARIA - Ariad Pharmaceuticals, Inc.
    By dark76 in forum Hot Stocks
    Replies: 3
    Last Post: 07-28-2009, 02:21 AM

Tags for this Thread

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts

Forum Rules